Vimarsana
Biggest News Aggregation in the World

Page 5 - Mark Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mark Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mark Foundation Today - Breaking & Trending Today

Snaking toward a universal antivenom - Vimarsana News

Snaking toward a universal antivenom

<p><em>Scripps Research scientists discovered antibodies that protect against a host of lethal snake venoms. &nbsp;</em></p>

Using cancer's strength to fight against it - Vimarsana News

Using cancer's strength to fight against it

<p style="text-align:left">Scientists at the UC San Francisco (UCSF) and Northwestern Medicine may have found a way around the limitations of engineered T cells by borrowing a few tricks from cancer itself.&nbsp;</p> <p style="text-align:left">By studying mutations in malignant T cells that cause lymphoma, they zeroed in on one that imparted exceptional potency to engineered T cells. Inserting a gene encoding this unique mutation into normal human T cells made them more than 100 times more potent at killing cancer cells without any signs of becoming to...

Board approves six faculty appointments - Vimarsana News

Board approves six faculty appointments

Four full professors and two assistant professors have been newly appointed to the Princeton University faculty.

Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies - Vimarsana News

Accent Therapeutics Announces $75 Million Series C Financing to Advance Small Molecule Precision Cancer Therapies

/PRNewswire/ -- Accent Therapeutics, a biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced the...

Accent Therapeutics Raises $75M in Series C Funding - Vimarsana News

Accent Therapeutics Raises $75M in Series C Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!